Request to Join
has invited you to join this group
Dr. Bertalan Mesko, PhD is The Medical Futurist and the Director of The Medical Futurist Institute analyzing how science fiction technologies can become reality in medicine and healthcare. As a geek physician with a PhD in genomics, he is also an Amazon Top 100 author. He is also a Private Professor at Semmelweis Medical School, Budapest, Hungary.
With 500+ presentations including courses at Harvard, Stanford and Yale Universities, Singularity University's Futuremed course at NASA Ames campus and organizations including the 10 biggest pharmaceutical companies, he is one of the top voices globally on healthcare technology. Dr. Mesko was featured by dozens of top publications, including CNN, the World Health Organization, National Geographic, Forbes, TIME magazine, BBC, and the New York Times. He publishes his analyses regularly on medicalfuturist.com.
Ezequiel "Zeke" Silva III, MD, FACR, FSIR, FRBMA, RCC, is Co-Chair of the American Medical Association's Digital Medicine Payment Advisory Group (DMPAG), a member of the AMA/Specialty Society RVS Update Committee (RUC) and Chairman of the RUC Research Subcommittee. He is a member of the American College of Radiology (ACR) Board of Chancellors and the chairman of the ACR Commission on Economics. He is a founding board member of the Neiman Health Policy Institute. He recently served as Co-Chair of two CMS Acumen Clinical Subcommittees. One on Peripheral Vascular Disease and the other on Hemodialysis Access Creation.
Dr. Silva has approximately 70 peer-reviewed publications and book chapters, as well as over 50 CME approved scientific lectures and exhibits to his credit. These are largely focused on payment policy, quality initiatives and digital medicine applications in health care. As lead author, Dr. Silva's 2016 paper on alternative payment models was awarded the "Best of 2016" by the Journal of the American College of Radiology.
In San Antonio, Dr. Silva is the Medical Director of Radiology at both the Methodist Texsan Hosptial and the Methodist Ambulatory & Surgical Hospital. He is an adjunct professor at UT Health - San Antonio.
Andrew Mebane Southerland, MD, MSc, FAHA is an Associate Professor in the Division of Vascular Neurology, Departments of Neurology and Public Health Sciences at the University of Virginia Health System. Dr. Southerland received his M.D. from the Brody School of Medicine at East Carolina University as a prestigious Brody Scholar. As a medical student, he won multiple academic awards including the AAN Medical Student Prize for Excellence in Neurology and induction into the Alpha Omega Alpha honor society. Dr. Southerland completed his internship at Carolinas Medical Center where he was named the Arnold R. Frazier Intern of the Year. He then completed Neurology Residency at the University of Virginia where he also served as chief resident. During his vascular neurology fellowship at UVA, Dr. Southerland completed a Master of Science in clinical research in the UVA Department of Public Health Sciences. As a faculty clinician, Dr. Southerland has received numerous accolades for teaching and clinical excellence, including a 2017 Bedside Manner Award from OurHealth Magazine.
Dr. Southerland is the past recipient of an early career award from the American Heart Association/American Stroke Association (AHA/ASA) National Clinical Research Program, and currently serves as Chair of the AHA/ASA Telestroke Committee and on the American Academy of Neurology Education Committee. Dr. Southerland also participated on the writing committee for the 2018 AHA/ASA Updated Guideline on the Management of Acute Ischemic Stroke. He serves as principal investigator or co-investigator for numerous stroke clinical trials. His primary research interests focus on innovative methods of prehospital stroke care, novel applications of telemedicine and telestroke, and gene by environment associations in non-atherosclerotic vasculopathies such as cervical artery dissection and fibromuscular dysplasia.
Dr. Southerland currently serves as the Executive Vice-Chair in the UVA Department of Neurology.
Psychiatry & Neurology - General Neurology, Vascular Neurology
Cervical artery dissection (carotid and vertebral artery dissection), fibromuscular dysplasia, novel applications of teleneurology and telestroke, prehospital stroke care, artificial intelligence and machine learning, acute stroke clinical trials
Ischemic Stroke, Hemorrhagic Stroke, Transient Ischemic Attack (TIA), Cerebral (Brain or Intracranial) Aneurysms, Cervical Artery Dissection, Fibromuscular Dysplasia, Other Cerebrovascular Diseases, General Neurology
East Carolina University Brody School of Medicine, Greenville, NC 2006
Carolinas Medical Center (Internal Medicine), Charlotte, NC 2007
University of Virginia Health System (Neurology), Charlottesville, VA 2010
University of Virginia Health System (Vascular Neurology), Charlottesville, VA 2012
Dr. Michael Repka is professor of ophthalmology and a professor of pediatrics at the Johns Hopkins University School of Medicine. He currently holds the David L. Guyton, MD, and Feduniak Family Chair in ophthalmology.
Dr. Repka has been at the Johns Hopkins University School of Medicine since 1983. He received his medical degree from the Jefferson Medical College of Thomas Jefferson University in 1979 and completed his ophthalmology residency at Wills Eye Hospital. Following completion of his residency training, a fellowship was spent training in pediatric ophthalmology and strabismus as well as neuro-ophthalmology at the Wilmer Ophthalmological Institute of Johns Hopkins Hospital. He completed his MBA at Johns Hopkins University in 2010.
He has contributed in the fields of pediatric ophthalmology, strabismus, retinopathy of prematurity and pediatric neuro-ophthalmology. His clinical practice includes an interest in the management of strabismus and amblyopia. In these areas, he has a special interest in using alternatives to patching for the management of amblyopia and using strabismus surgery, botulinum toxin and adjustable sutures to treat strabismus. He performs cataract surgery and intraocular lens implantation on children with cataracts. He has a special interest in pediatric neuro-ophthalmology. He led the Pediatric Eye Disease Investigator Group from 1997 to 2009 as chair and currently serves as past chair for and member of the operations committee. PEDIG’s network has conducted more than 20 clinical trials in pediatric ophthalmology funded by the National Eye Institute.
Dr. Repka currently is Vice-chair for Clinical Practice of the Wilmer Institute and Division Director of Pediatric Ophthalmology and Adult Strabismus at the Wilmer Institute of Johns Hopkins University. He also serves as the Medical Director for Governmental Affairs of the American Academy of Ophthalmology. He is a past chair of the FDA’s Ophthalmic and Dermatological Advisory Committee and is currently AAO’s CPT Advisor to the AMA’s CPT Editorial Panel.
Sonoo Thadaney-Israni is the co-founder and Executive Director of the Stanford Presence Center, with Faculty Founding Director, Dr. Abraham Verghese. She also serves as the co-chair of the Working Group of Artificial Intelligence in Healthcare for the National Academy of Medicine (NAM, erstwhile the Institute of Medicine) in Washington D.C. USA and co-shepherds the work of the NAM's Technology across the Lifecourse Group.
Sonoo spent almost three decades working in Silicon Valley before moving to Stanford University. At Stanford, she has been an internal entrepreneur, working with faculty to launch the Stanford Presence Center, the new MSc. in Community Health and Prevention Research, the Stanford WSDM (Women and Sex Differences in Medicine) Center, the Diversity-First Gen Office (serving students who are first in their family to attend college), the Restorative Justice Pilot and more. Sonoo teaches coursework in Leveraging Conflict for Constructive Change, Leadership Skills and Mediation.
Sonoo formal education includes an MBA, a BA in Psychology, with Minors in Sociology and Education, and a Post-Baccalaureate in Mass Communications. She is also a trained Mediator and Restorative Justice practitioner for the State of California, serving as the Co-Chair of the Commission on Juvenile Delinquency and Prevention for San Mateo County.
Dr. Marlene Grenon is the Chief Medical Officer of Evry Health, a new commercial health insurance company as well as a vascular medicine specialist and Associate Clinical Professor (volunteer) in the Department of Surgery at UCSF. She has more than 20 years of experience in the health care industry. Prior to joining the team at Evry Health, Dr. Grenon held the position of Associate Professor in the Department of Surgery at UCSF, vascular surgeon at the VAMC San Francisco and Adjunct Faculty at the International Space University. She has been heavily involved in research and education, acting as lead investigator for several clinical trials funded by the NIH and NASA/NSBRI.
Dr. Grenon holds an MD from McGill University, a MMSc from Harvard Medical School, an MBA from Brown University and IE Business School, and a diploma in Space Sciences from the International Space University. She completed a residency in cardiac surgery (McGill) and fellowships in vascular surgery (University of British Columbia) and aerospace medicine research (Harvard/MIT). She is a diplomate of the American Board of Vascular Medicine, a fellow from the Royal College of Physicians and Surgeons of Canada (RCPSC) with Certificate of Specialist in both cardiac and vascular surgery from RCPSC. She advises start-ups in the Bay Area with a focus on digital health.
Dr. Chang attended Johns Hopkins University for his B.A. in molecular biology prior to entering Georgetown University School of Medicine for his M.D. He then completed his pediatric residency at Children’s Hospital National Medical Center and his pediatric cardiology fellowship at the Children’s Hospital of Philadelphia. He then accepted a position as attending cardiologist in the cardiovascular intensive care unit of Boston Children’s Hospital and as assistant professor at Harvard Medical School.
He has been the medical director of several pediatric cardiac intensive care programs (including Children’s Hospital of Los Angeles, Miami Children’s Hospital, and Texas Children’s Hospital). He served as the medical director of the Heart Institute at Children’s Hospital of Orange County.
He is currently the Chief Intelligence and Innovation Officer (CIIO) and Medical Director of the Heart Failure Program at Children’s Hospital of Orange County. He has also been named a Physician of Excellence by the Orange County Medical Association and Top Cardiologist, Top Doctor for many years as well as one of the nation’s Top Innovators in Healthcare.
He has completed a Masters in Business Administration (MBA) in Health Care Administration at the University of Miami School of Business and graduated with the McCaw Award of Academic Excellence. He also completed a Masters in Public Health (MPH) in Health Care Policy at the Jonathan Fielding School of Public Health of the University of California, Los Angeles and graduated with the Dean’s Award for Academic Excellence. Finally, he graduated with his Masters of Science (MS) in Biomedical Data Science with a subarea focus in artificial intelligence from Stanford School of Medicine and has completed a certification on artificial Intelligence from MIT. He is a computer scientist-in-residence and a member of the Dean’s Scientific Council at Chapman University.
He is the founder and medical director of the Medical Intelligence and Innovation Institute (MI3) that is supported by the Sharon Disney Lund Foundation. The institute is dedicated to implement data science and artificial intelligence in medicine and is the first institute of its kind in a hospital. The new institute is concomitantly dedicated to facilitate innovation in children and health care all over the world. He is the organizing chair for the biennial Pediatrics2040: Emerging Trends and Future Innovations meeting as well as the founder and director of the Medical Intelligence and Innovation Summer Internship Program, which mentors close to 100 young physicians-to-be every summer. He has organized a pediatric innovation leadership group called the international Society for Pediatric Innovation (iSPI).
Dr. Michael D. Abramoff, MD, PhD, is a fellowship-trained retina specialist, computer scientist and entrepreneur. He is Founder and CEO of IDx, the first company ever to receive FDA clearance for an autonomous AI diagnostic system. In this capacity, as an expert on AI in healthcare, he has been invited to brief the US Congress, the White House and the Federal Trade Commission. He continues to treat patients with retinal disease and trains medical students, residents, and fellows, as well as engineering graduate students at the University of Iowa.
Dr. Abramoff has published over 260 peer reviewed journal papers (h-index 57) on AI, image analysis, and retinal diseases, and many book chapters, that have been cited over 27,000 times. He is the inventor on 17 patents and 5 patent applications on AI, medical imaging and image analysis. In 2010, Dr. Abramoff’s research findings led him to found IDx, to bring to patients more affordable, more accessible, and higher quality healthcare.
IDx is a leading AI diagnostics company on a mission to transform the quality, accessibility, and affordability of healthcare. The company is focused on developing clinically-aligned autonomous AI. By enabling diagnostic assessment in primary care settings, IDx aims to increase patient access to high-quality, affordable disease detection. In 2018, IDx became the first company ever to receive FDA clearance for an autonomous AI diagnostic system. The system, called IDx-DR, detects diabetic retinopathy without requiring a physician to interpret the results.